BRIEF-Prelude Therapeutics Q3 EPS USD -0.43

Reuters
07 Nov 2024
BRIEF-Prelude <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Q3 EPS USD -0.43

Nov 06 (Reuters) - Prelude Therapeutics Q3 operating expenses USD 37.376 million.

  • Q3 income from operations USD -34.376 million
  • Q3 net income USD -32.271 million

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10